Navigation Links
Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
Date:4/5/2011

l strength while remaining flexible and durable, which is critical to sustaining patency in treated SFA and PPA lesions."

"The INNOVA Stent is engineered to offer an advanced solution in treating blockages within these critical arteries," said Joe Fitzgerald, Senior Vice President and President of Boston Scientific's Endovascular Unit.  "Its design is intended to improve blood flow and provide greater long-term stent durability, ultimately improving the overall quality of life for patients with peripheral artery disease."

The INNOVA™ Stent System received CE Mark in March, and the Company plans to begin marketing the product in the EU and other countries in the second quarter of 2011.  In the U.S., it is an investigational device, limited by applicable law to investigational use only and not available for sale.  

About Boston ScientificBoston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.  For more information, please visit: www.bostonscientific.com.  

Cautionary Statement Regarding Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words.  These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.  These forward-looking statements include, among other things, statements regarding new product launches and launch cadence, regulatory approvals, clinical trials, product performance and com
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will ... March 31, 2013, before market on Tuesday, May 28, 2013.  ... 28, 2013, at 8:00 a.m. EDT (May 28, 2013 at ... results and provide an update on recent corporate developments. ...
(Date:5/16/2013)... SOUTH PLAINFIELD, N.J. , May 16, 2013 /PRNewswire/ ... a registration statement on Form S-1 with the U.S. ... initial public offering of its common stock. The number ... for the offering have not been determined. ... and Credit Suisse are acting as joint book-running managers ...
(Date:5/16/2013)... -- Alere Inc. (NYSE: ALR ), a global leader ... home through the merger of rapid diagnostics and health management, ... its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).  The ... record of Series B stock at the close of business ... the amount of all dividends accrued from April 1, 2013 ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... 2012 Hill-Rom Holdings, Inc., (NYSE: HRC ) ... Leerink Swann 2012 Global Healthcare Conference in New York City ... You are invited to listen to the live discussion via ... at http://wsw.com/webcast/leerink23/hrc/ .  A recorded replay of the discussion ...
... COPENHAGEN, Denmark, February 1, 2012 Pharmaceutical ... for electronic regulatory submissions services. Today, the company announced ... In this role, Mr. Kumar will contribute, together with ... for the life science industry, developing strategies and plans ...
Cached Medicine Technology:Shylendra Kumar Joins Pharmaceutical eConsulting 2
(Date:5/19/2013)... 19, 2013 The Da Vinci robot ... developments in the nation’s first trial involving a Da ... Washington State Superior Court, was filed by the widow ... suffered complications in a robot-assisted prostate removal, according to ... Vinci robotic surgery lawsuit alleges those complication’s hastened ...
(Date:5/18/2013)... Daily Gossip issued a press release last week to ... John Colston, Daily Gossip’s spokesperson, told the press that the ... Rapid Fat Loss Plan . , Shaun Hadsall was ... a time when nutritionists and fat loss gurus constantly told ... The diet is based on the Macro-Patterning scheme, ...
(Date:5/18/2013)... 19, 2013) The American Gastroenterological Association (AGA) ... research scholars. This year,s honorees are outstanding young ... or related areas, and with this award, their ... young researchers are the future of our field. ... are paving the way for promising research developments ...
(Date:5/18/2013)... (PRWEB) May 19, 2013 Illuminations is proud ... Trisha Caetano. Seminars will take place over the course ... Friday, June 7, and Saturday, June 8, 2013. , Inner ... symptoms, but focuses on the attitudes, patterns and coping mechanisms ... symptoms. Participants will learn to live a more integrated and ...
(Date:5/18/2013)... Just a few extra cups of coffee each month ... disease known as primary sclerosing cholangitis (PSC), a new ... Rochester, Minn., found that drinking coffee was associated with ... lead to cirrhosis of the liver, liver failure and ... cause-and-effect relationship. "While rare, PSC has extremely ...
Breaking Medicine News(10 mins):Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4Health News:AGA Research Foundation Research Scholar Awards advance the work of promising gastroenterologists 2Health News:Illuminations Brings World Renowned Therapist to the Middle East 2Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2
... , Jan. 29 The Minnesota Medical Association Board ... to save the General Assistance Medical Care (GAMC) program, but not ... existing payments already do not cover the cost of providing care. ... would support health care programs. The MMA sent a letter to ...
... , LOS ANGELES , Jan. 29 In a ... the nation,s organ donation and transplant community will vote for the best ... Seven Pounds , Return to Me , John Q ... Philadelphia Transplant Movie Night, a group of transplant recipients, living donors and ...
... Project A.L.S. (New York, NY) and the Robert Packard ... MD) announced that they will partner on, P2 ALS, ... Gehrig,s disease) research exponentially over the next three years. ... leaders in forging productive collaborations among research scientists, will ...
... study finds , FRIDAY, Jan. 29 (HealthDay News) -- Genital ... that may help improve treatment and prevention, U.S. researchers say. ... seven separate genital sites in four women infected with herpes ... than one area on 56 percent of days when there ...
... , DALLAS , Jan. 29 ... charities from across the nation will be participants in its Medical ... Company has increased its giving by 23 percent in 2010, the ... million in transportation to 29 medical organizations who then provide ...
... CHARLOTTESVILLE, Va. , Jan. 29 Lodewijk J.R. ... industries, was elected to the Board of Directors of the Focused ... will serve a term of three years. , A founding partner ... Vink,s earlier executive positions included Chairman, International Health Care Partners; Chairman, ...
Cached Medicine News:Health News:Doctors Tell Lawmakers to Find a New GAMC Fix 2Health News:Nationwide Vote to Determine Best Organ Donation-Themed Movie 2Health News:Project A.L.S. and Packard Center take aim at ALS with $15 million program 2Health News:Southwest Airlines Announces Recipients of its 2010 Medical Transportation Grant Program 2Health News:Lodewijk de Vink Elected to Board of Focused Ultrasound Surgery Foundation 2Health News:Lodewijk de Vink Elected to Board of Focused Ultrasound Surgery Foundation 3
Richardson Blade - for use with Bookler Universal Table Mounted Retractor Systems...
Richardson Retractors...
... term being used today to describe the nature of ... may have been used in silicone implants in the ... not new technology cohesive is simply a word ... nature of the gel. All of Mentor silicone gel-filled ...
A full, rounded look that adds greater dimension to the breast. Moderate base, with a higher profile than our Style 1600 implant....
Medicine Products: